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 ABSTRACT 
 
Atherosclerosis is a decades-long process whose patients often remain asymptomatic until after a 
heart attack or stroke.  Novel therapeutic approaches focus on tuning the body’s own 
atheroprotective mechanisms to induce regression. My approach looks at macrophages, which is 
the most prominent immune cell type in atherosclerotic plaque due to its involvement in lipid 
clearance, apoptotic cell debris clearance and pro- or anti-inflammatory cytokine production. 
While the molecular mechanisms active in lesional macrophages have been extensively studied, 
the effect of age- and inflammation-induced arterial stiffening on macrophage function is not yet 
fully understood. Thanks to recent advances in bioengineering that provided the tools to mimic 
physical properties of tissue, the effect of physical stiffness and associated matrix remodeling on 
macrophages can now be studied. Herein I describe the effects of physical substrate stiffness on 
macrophage behavior relevant to atherosclerosis plaque formation using a polyacrylamide 
hydrogel-based in vitro model of atherosclerotic tissue.
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 CHAPTER 1 
INTRODUCTION 
 
In the US, heart disease is the leading non-accidental cause of death. In 2012, it was projected 
that each minute someone died from a heart disease-related cause in the US. It is prevalent in all 
racial/ethnic groups, being the leading cause of death in African Americans, Hispanics and 
Caucasians and second only to cancer in Asian Americans, Pacific Islanders, Native Americans 
and Alaska Natives. The cost of coronary heart disease alone is estimated to cost the US $108.9 
billion each year in terms of health care services, medications and lost productivity (Go, 2014). 
 
Key factors contributing to the increase in heart disease risk are high blood pressure, high LDL 
cholesterol and smoking (smoking alone doubles myocardial infarction risk)  (Go, 2014). Certain 
lifestyle choices such as excessive alcohol use, poor diet, lack of physical exercise and obesity 
also play a major role in increasing heart disease risk, as do medical conditions such as diabetes. 
With the ‘baby boomer’ population of the US crossing the 60-year mark, age-related risk factors 
are also contributing to the projected surge in heart disease cases faced by the medical 
community. There is an increasingly great need to understand and treat the diseases of the heart, 
and perhaps none more so than atherosclerosis. 
 
Atherosclerosis (Greek: athero (gruel; paste) and sclerosis (hardness)) is a form of 
cardiovascular disease characterized by the thickening of an artery wall as a result of the buildup 
of fatty substances, cholesterol, cellular debris, calcium and fibrin in the inner lining of the 
artery, forming a ‘plaque’. While some thickening and hardening of the arteries is a part of the 
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normal aging process, advanced atherosclerotic plaques can carry the risk of partially or 
completely blocking blood flow through the artery, resulting in strokes or heart attacks. 
Atherosclerotic plaques are of two types: stable and unstable. Stable plaques, generally rich in 
extracellular matrix (ECM) proteins and smooth muscle cells, tend to be asymptomatic. Unstable 
plaques, in contrast, are rich in macrophages, foam cells and cellular debris with a relatively 
weak but stiff fibrotic cap, which is prone to rupture (Virmani, 2002). Rupture of such unstable 
plaques can lead to the accumulation of the debris in the arteries, causing inappropriate clotting 
activity and the formation of a blood clot within the vessel, called a thrombus. Such thrombi can 
occlude arteries outright (coronary occlusion) or can break up and move downstream to block 
smaller branches of the arterial system (thromboembolism). This loss of blood flow is a major 
cause of heart attacks and strokes. In addition, chronic atherosclerotic lesions can cause 
occlusion without detaching, but remain asymptomatic until about 80% of the artery is blocked 
(stenosis), where downstream blood supply to tissue is so low as to cause tissue damage 
(Virmani, 2002). Clinically urgent atherosclerosis is most often exhibited in adults over 45 years 
of age, but the first signs of atherosclerosis (sub-clinical atherosclerosis) can start to appear as 
early as infancy or even birth (Go, 2014). Thus, atherosclerosis is a major health risk that can go 
undetected for a long period of time before detection and treatment. Therefore, there is an urgent 
need to fully understand the mechanisms that promote atherosclerotic plaque formation in order 
for risk determination and early detection to be effective in atherosclerosis treatment. 
 
Atherosclerotic tissues exhibit a wide range of mechanical stiffnesses, from the pliable fatty 
streaks of early lesions and the necrotic core of advanced plaques, to the calcified fibrotic caps 
present in advanced lesions (Tracqui, 2011). Lesion progression changes the elastic environment 
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of the artery wall to that of a compliant core capped with a tough sheath. Since cellular function, 
specifically macrophage function, is affected by the mechanical properties of the environment 
response (Fereol, 2006; Vonna, 2007; Flannagan, 2010; Patel, 2012) and macrophages play an 
important role in atherosclerosis progression, there is a need to determine the effect of substrate 
stiffness on macrophage functions relevant to atherosclerosis. To answer this question, I utilized 
a 2-dimensional polyacrylamide hydrogel matrix to model atherosclerotic tissues of various 
stiffnesses. I plated macrophages on the gel assemblies and determined the effect of variation in 
substrate stiffness on three macrophage functions that are important in atherosclerosis: secretion 
of inflammatory cytokine, phagocytosis and lipid handling. I found that decrease in substrate 
stiffness increases inflammatory cytokine secretion and lipid retention while decreasing 
phagocytotic activity. Furthermore, I attempted to disrupt the mechanisms by which 
macrophages sense the mechanical properties of their environment (a process known as 
mechanosensing) and evaluate the resultant effect, if any, on inflammatory cytokine production. 
While initial results were inconclusive, there was some evidence suggesting that disruption of 
mechanosensing may indeed affect the inflammatory response in macrophages. This information 
may provide for the creation of novel atherosclerosis therapeutic strategies that target 
inflammation. 
 
1.1 Atherosclerosis and Macrophages 
Atherosclerotic lesions predominantly occur in arteries at sites where laminar blood flow is 
disturbed, such as arterial branch points and bifurcations (Moore, 2011). Studies of the earliest 
stages of atherosclerosis suggest that a key step is initiating accumulation of apolipoprotein B-
containing lipoproteins (LPs) in the subendothelium (Williams and Tabas, 1995). The early 
4 
inflammatory response to retained apoB-LPs is activation of the overlying endothelial cells in 
order to recruit blood-borne monocytes (Glass and Witztum, 2001; Mestas and Ley, 2008). 
Monocytes are recruited by chemokines, which can be prevented by blocking the chemokines or 
their receptors, thus retarding atherogenesis in mouse models (Mestas and Ley, 2008). 
Macrophages arising from these monocytes secrete apoB-LP-binding proteoglycans (Williams 
and Tabas, 1995), which contribute to amplification of LP retention and subsequent failure of 
inflammatory resolution in atherosclerotic lesions and maintenance of inflammation. Reduction 
in macrophage numbers due to lack of macrophage colony-stimulating factor (M-CSF) confers 
protection from atherosclerosis in ApoE deficient mice in spite of hyperlipidemia (Smith, 1995; 
Rajavashisth, 1998). In the absence of M-CSF, monocyte-macrophages are no longer recruited to 
the subendothelial region and can no longer scavenge the accumulated lipid to form lipid loaded 
foam cells that can accumulate to form fatty streaks and eventually complex fibrous lesions. 
Normal macrophage presence and function is therefore necessary to control atherosclerotic 
plaque formation. 
 
1.2 Macrophages and lipid handling 
Monocyte differentiation into macrophages is driven by multiple factors, such as M-CSF and 
granulocyte-macrophage colony-stimulating factor (GM-CSF). In atherosclerotic lesions, 
monocytes primarily become cells that have features of macrophages and/or dendritic cells 
(Johnson and Newby, 2009; Paulson et al., 2010). In all stages of atherogenesis, many 
macrophages and dendritic cells have membrane bound lipid droplets in the cytoplasm. These 
lipid-loaded cells are called foam cells, and are formed when phagocytes ingest and process 
apoB-LPs. Once ingested, the cholesteryl esters of LPs are hydrolyzed in late endosomes to 
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cholesterol and fatty acids (Maxfield and Tabas, 2005). Delivery of free cholesterol to the 
endoplasmic reticulum normally suppresses the sterol-regulatory element binding pathway 
(SREBP) and downregulates endogenous cholesterol synthesis (Brown and Goldstein, 1997), 
which controls fat buildup in a healthy individual. Free cholesterol undergoes re-esterification to 
cholesteryl fatty acid esters due to the ER enzyme acyl-CoA:cholesterol ester transferase 
(ACAT) (Brown, 1980). Cholesterol efflux, where free cholesterol released from lysosomes and 
from rehydrolyzed cholesteryl ester droplets traffic to the plasma membrane and efflux out of the 
macrophage (Tall et al., 2008; Rothblat and Philips, 2010), is thought to be a major player in 
atherosclerotic plaque regression upon reversal of hypercholesterolemia. In atherosclerosis, 
defects in cholesterol efflux from cells or in ACAT function lead to free cholesterol-induced 
toxicity and may promote macrophage death in advanced atherosclerotic lesions (atheromata) 
(Yvan-Charvet, 2007; Zhu, 2008; Tang, 2009). Additionally, free cholesterol efflux appears to be 
defective in lesional macrophages, which may explain the lack of lesion regression (Jerome, 
2006). Macrophages, therefore, play a central role in lipid handling and clearance and loss of 
these functions is an important factor in plaque formation and progression. 
 
Numerous factors that retard plaque progression have been discovered. Research has shown that 
sterol-regulated transcription factors liver X receptor (LXRα and LXRβ) induce the ABC 
transporter proteins ABCG1 and ABCA1 and assist in regression of foam cell lesions (Calkin 
and Tontonoz, 2010), confirmed by targeting these genes in mice and injecting them with 
macrophages containing radiolabeled cholesterol, then tracking the appearance of the radiolabel 
in blood and feces (deGoma, 2008). ABCA1 and ABCG1 aid in cholesterol efflux from lipid-
laden macrophages by translocating phospholipids and cholesterol onto nascent High Density 
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Lipoprotein (HDL) particles (Vedhachalam, 2007; Gillotte-Taylor, 2002, Wang, 2004, 2006). 
Statin drugs, which lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase 
(which plays a central role in cholesterol production in the liver), also act by upregulating or 
downregulating ABC transporter expression according to cellular cholesterol abundance or 
scarcity respectively (Wong, 2008).  As a result, therapeutic strategies to promote lesion 
regression include enhancing macrophage cholesterol efflux by increasing HDL (or similar 
particles) content or upregulating ABC transporter function (Tall et al., 2008; Rothblat and 
Philips, 2010). 
 
One of the central unanswered questions in atherogenesis is how loading of macrophages with 
lipoprotein derived-cholesterol promotes proatherogenic activities of macrophages. Even under 
normal cholesterol esterification conditions, macrophages upon exposure to atherogenic 
lipoproteins undergo cholesterol enrichment in the plasma membrane, which may enhance 
inflammatory signaling through clustering-mediated activation of signaling receptors 
(TLR4/CD14) due to the increased order of parameter of cholesterol-enriched membranes 
(Yvan-Chavet et al., 2007, Zhu et al., 2008; Tang et al., 2009). Modified lipoproteins such as 
oxysterols and oxidized phospholipids delivered via uptake of oxidized lipoproteins can induce 
macrophage apoptosis. Apoptotic cells that are not cleared by macrophages via phagocytosis can 
eventually no longer maintain plasma membrane integrity. These cells then rupture, releasing 
pro-inflammatory cellular debris into the environment and thus promoting atherogenesis. Effects 
of lipoprotein loading were studied by gene ontology analysis of proteins differentially expressed 
by peritoneal macrophages from isocaloric- vs. fat-fed Low-Density Lipoprotein Receptor 
(Ldlr)-deficient mice (which have high LDL levels and develop atherosclerosis on a high-fat 
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diet) (Becker et al., 2010). A large number of proteins, mediated by a decrease in ApoE 
expression in the cholesterol-loaded macrophages and previously implicated in lesion 
development in gene-targeted mouse models, were found to have differential expression. Upon 
treatment with atherosclerosis-decreasing drugs (a statin and a thiazolidinedione), the difference 
in lesion development-related gene expression profiles in macrophages between the normal- and 
fat-fed Ldlr- mice decreased. Such studies have provided vital information regarding the 
macrophage response to protein loading in vivo and have also shown the applicability of systems 
biology approaches to atherosclerotic disease research. 
 
1.3 Inflammatory Activation of Macrophages in Atherosclerotic Lesions 
The mechanisms and effects of macrophage-mediated inflammation are an important aspect of 
atherosclerosis and a central focus in research. Inflammation markers were identified using 
immunohistochemistry and RNA analysis of laser capture micro-dissection isolated plaque 
macrophages from animal models and human tissues (Shibata and Glass, 2009). Several studies 
examining the effect of pro- or anti-inflammatory reagents and genes have revealed that factors 
that decrease inflammation also have a protective effect on lesion area. Selective ablation of the 
IκB kinase gene (involved in NF-kB activation in macrophages and neutrophils) in mice and 
subsequent donation of bone marrow to Ldlr knockout mice kept on a high fat diet resulted in an 
increase in atherosclerotic area in spite of a ~50% decrease in NF-kB activation and LPS-
induced TNFα (Kanters et al., 2003). In contrast, endothelial-targeted inhibition of NF-kB 
signaling in Apoe knockout mice resulted in a decrease in lesion area due to a decrease in the 
recruitment of macrophages to lesions (Gareus, 2008). Monocyte-derived macrophages cultured 
from Ldlr knockout mice upon LPS treatment showed decreased IL-10 secretion (IL-10 being 
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atheroprotective in mice) (Han, 2010).  Global deletion of members of the Toll-like Receptor 
(TLR) family (which include NF-κB in their activation pathways leading to proinflammatory 
cytokine production in macrophages) decrease lesion area in fat-fed Ldlr- or Apoe- deficient 
mice (Curtiss and Tobias, 2008). TLRs, key components of the innate immune system, elicit both 
protective and detrimental roles in atherosclerosis. Ldlr-deficient mice fed a high-fat diet and 
transplanted with bone marrow from Tlr2- deficient mice showed a decrease in lesion size only 
upon challenge with TLR2 agonists (Mullick et al., 2005). TLR3 deletion in Ldlr-knockout mice 
significantly reduced inflammation and atherosclerotic burden (Lundberg, 2013). TLR4 loss in 
ApoE-deficient mice reduced atherosclerosis and altered plaque phenotype (Michelsen, 2004). 
The TLR4/TLR6 heterodimer cooperates with CD36 in activating NF-kB in response to oxidized 
LDL (Stewart et al., 2010). In contrast, TLR7 plays an atheroprotective role by interfering with 
the proinflammatory responses to TLR2 and TLR4 ligands, as functional inactivation of TLR7 in 
ApoE-deficient mice led to accelerated lesion development and increased plaque vulnerability 
(Salagianni, 2012). Fat-fed Ldlr- knockout mice transplanted with bone marrow from Cd40- 
knockout mice also showed a reduction in lesion area and inflammation (CD40 being a 
macrophage receptor with the capability to trigger NF-kB activation) (Lutgens et al., 2010). 
Exposing macrophages to cholesterol crystals, present in atherosclerotic plaques from early on, 
induces inflammation via an inflammasome complex comprised of multiple proteins such as 
NLRP3, ASC and caspase-1. In Ldlr- knockout mice fed a fat-rich diet, transplantation with 
marrow cells lacking NLRP3 or ASC resulted in a decrease in lesion size and levels of the 
proinflammatory cytokine IL-18 (Duewell, 2010; Rajamaki, 2010). Thus, multiple inflammation 
factors have been identified as playing a role in lesion formation, providing opportunities to 
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develop novel therapeutic strategies that target inflammation pathways in order to cause lesion 
regression or prevention. 
1.4 Defective Efferocytosis in Atherosclerotic Lesions 
The greatest health risk posed by advanced atherosclerotic plaques is the risk of plaque rupture, 
which can lead to thrombosis (blockage of the vessel lumen) and release of the toxic products of 
cell necrosis (toxic enzymes, oxidants, proteases, caspases etc.) from the necrotic core. Necrotic 
cores arise from the combination of apopotosis of advanced lesional macrophages and defective 
phagocytotic clearance (efferocytosis) of the apoptotic cells in advanced plaques (Tabas, 2010). 
In early lesions the efferocytic clearance is efficient enough to cause decreases in lesion 
cellularity, inflammation and plaque progression rather than an increase in plaque necrosis. At 
that stage, macrophages are able to clear cells before membrane damage leads to extracellular 
leakage of toxic intracellular material. This triggers an IL-10 and TGF-β –mediated anti-
inflammatory response in the efferocytes and promotes efferocyte survival by protecting them 
from potentially toxic factors present in the apoptotic cells. Macrophage death in advanced 
lesions can be due to any of a number of processes – growth factor deprivation, oxidative stress 
and/or death receptor activation (Tabas, 2010). 
 
Excess apoB-LP buildup in the subendothelial space causes endothelial and smooth muscle cell 
toxicity and death, the products of which would normally be cleared by efferocytosis. Once 
efferocytic clearance is unable to sufficiently clear the apoptotic cells, the apoptotic cells build 
up, causing secondary necrosis and release of inflammatory cellular contents into the 
subendothelial space.  Normal efferocytic clearance involves robust esterification and efflux of 
cholesterol, efflux of proapoptotic oxidized lipids, and activation of Akt and NF-kB cell survival 
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pathways. Efferocytosis is carried out via phagocytotic receptors such as tyrosine kinase MerTK, 
low-density lipoprotein receptor-related protein 1 (LRP-1), apoptotic cell ligands such as 
phosphatidylserine and C1q and bridging molecules such as Growth arrest-specific 6 that 
recognize apoptotic cells (Henson et al., 2001). Since efferocytosis is a high-capacity process and 
its throughput is unaffected by artificially increased apoptotic rates (via genetic manipulation in 
early atherosclerotic lesions) (Tabas, 2010), the combination of overabundant apoptotic 
macrophages and widespread tissue necrosis causing plaque necrosis would imply that the 
process of efferocytosis itself becomes defective in advanced atherosclerotic lesions. There are 
multiple possible explanations for this loss of function, such as oxidative stress-induced 
macrophage death due to defective cholesterol efflux after apoptotic cell engulfment (Yvan-
Charvet et al., 2010); LP-associated hydrolysis of oxidized phosphatidylserine on apoptotic cell 
surfaces by phospholipase A2 (Wilensky and Macphee, 2009); and/or protease-mediated 
cleavage of the efferocytosis receptor MerTK (Sather et al., 2007). Since atherosclerosis and 
obesity are two highly-correlated health risks, there is also the potential explanation of defective 
engulfment of apoptotic cells by macrophages that have been exposed in vivo or in vitro to 
saturated fatty acids, possibly due to changes in plasma membrane structure (Li et al., 2009). 
 
1.5 Mechanosensing and Atherosclerosis.  
While cytokine and chemokine cues are critical ways to influence cell fate and function, several 
recent studies provide evidence that cells sense and respond to their physical environment in a 
process known as mechanosensing. Naïve mesenchymal stem cells (MSCs) can be committed to 
specific lineage and phenotypes by altering the stiffness of the growth substrate, even when 
cultured in the same mix of growth and differentiation factors. MSCs grown on softer substrates 
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mimicking nervous tissue had neuron-like RNA expression profiles and had osteocyte-like RNA 
expression on stiffer substrates mimicking bone (Engler, 2006). This matrix stiffness-dependent 
lineage commitment of MSCs is mediated by the α2-integrin subunit of the α2β1 integrin, via 
intracellular signaling through the mechanotransducers Rho kinase (ROCK) and focal adhesion 
kinase (FAK) (Shih, 2011). ROCKs are downstream targets of the small GTP-binding protein 
RhoA. ROCKs are characterized for their roles in mediating the formation of RhoA-induced 
stress fibers and focal adhesions, changing the actin cytoskeletal structure through effects on 
myosin light chain phosphorylation (Leung, 1996; Somlyo, 2000). Matrix stiffness thus has a 
role in stem cell fate determination, driven by mechanotransducer kinase-driven mechanosensing 
events. 
 
Effects of substrate mechanical stiffness are not limited to undifferentiated cells alone. 
Endothelial cells cultured on hydrogels mimicking the elasticity of young or aging arterial inner 
walls (intima) show increased permeability and disrupted cell-cell junctions on stiffer matrices 
(aged intima) (Huynh, 2011). This destabilization of cell-cell junctions was due to increased 
contractility of endothelial cells on stiffer substrates. The increased permeability of the 
endothelium results in increased monocyte extravasation, leading to accumulation in the 
subendothelial region and triggering atherogenesis. Endothelial integrity was restored by 
inhibiting ROCK via the chemical inhibitor Y-27632 or via small interfering RNA. 
The ability of culture substrates to affect cell adhesion and focal adhesion rates has been 
documented in macrophages (Van Goethem, 2010) as well as non-macrophage cells (kidney 
epithelial and 3T3 fibroblast cells, Pelham 1997), but recent studies have shown that the 
mechanical stiffness of substrates also dynamically affect macrophage elasticity (Fereol, 2006; 
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Vonna, 2007; Flannagan, 2010; Patel, 2012) and by extension, could also affect macrophage 
functions such as phagocytosis and inflammatory response. 
 Mechanical stiffness studies have found that the fatty streaks in early plaque and the necrotic 
core of advanced plaques have a Young’s modulus of stiffness of 5-9 kPa, while the calcified 
hypocellular fibrotic regions of advanced plaques have a much higher Young’s modulus of 
~100kPa (Tracqui, 2011). Given the considerable heterogeneity in both mechanical properties 
and macrophage populations (atherogenic, inflammatory macrophages and atheroprotective, anti-
inflammatory macrophages) (Stoger, 2010), there is reason to investigate the hypothesis that the 
variations in substrate mechanical stiffness within atherosclerotic lesions affect monocyte-to-
macrophage differentiation and atherogenic progression biases macrophage function to be pro-
inflammatory and atherogenic. 
 
1.6 Outline of Thesis Research 
Macrophage cells play a very important role in determining the fate of an atherosclerotic lesion, 
since loss of their abilities to clear lipid loads and efferocytose apoptotic cells is a major factor in 
lesion progression to advanced plaque stages. Based on the studies discussed above, we 
hypothesized that substrate stiffness plays an important role in regulating the ability of 
macrophages to clear lipid loads and apoptotic cells in atherosclerotic lesions. Based on previous 
research on mimicking matrix elasticities (Pelham, 1997; Huynh, 2011), we devised a means to 
study the effect of substrate stiffness on macrophages, by plating them on thin polyacrylamide 
gels laid on glass coverslips. By tuning the ratio of acrylamide to bis-acrylamide in the gel, we 
were able to fabricate gels of various stiffnesses (Young’s modulus of 1kPa – 100 kPa). Once 
plated across differing substrate stiffnesses, we evaluated the plated macrophages for variations 
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in morphology, immune/inflammatory response to stimulation with TLR agonists (cytokine 
production), lipid handling and clearance, phagocytotic efficiency, the effect of inhibition of rho 
kinases (involved in mechanosensing) on cell morphology and reaction to TLR agonists and the 
effect of inhibition of actin cytoskeleton polymerization and reorganization on reactivity to TLR 
agonists. 
 
There were several major findings from my thesis work. Cells plated on more compliant (softer) 
substrates adopted a spherical shape with lower numbers of focal adhesion bodies than those 
plated on stiffer substrates. Cells on softer substrates produced more proinflammatory cytokine 
(TNF-α) upon stimulation and had increased lipid uptake and retention but lower phagocytotic 
activity. Inhibition of rho kinases and actin polymerization immediately prior to stimulation of 
proinflammatory cytokine production did not alter TNF-α production. Loss of mechanosensing 
in macrophages due to rho kinase inhibition resulted in formation of new actin projections and 
focal adhesion bodies to resume mechanosensing, the frequency of which increased with 
increase in substrate stiffness. Rho kinase phosphorylation was found to be increased in cells 
plated on stiffer substrates, showing that rho kinases play a role in mechanosensing in 
macrophages.
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CHAPTER 2 
 
MATERIALS AND METHODS 
2.1 Cell Culture 
RAW 264.7 cells (ATCC #TIB-71) cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) with 2mM L-glutamine, 50 U/ml penicillin, 50ug/ml streptomycin, 10mM HEPES, 
1mM sodium pyruvate and 10% low endotoxin FBS. Cells were cultured from thawed passage 
tested negative for mycoplasma prior to freezing. 
 
Bone marrow cells were flushed from the femur of a C57BL/6 mouse and cultured in bone 
marrow-derived macrophage (BMM) media (DMEM supplemented with 2mM L-glutamine, 50 
U/ml penicillin, 50ug/ml streptomycin, 10% supernatant from L929 cells, and 10% low 
endotoxin FBS) for five days (three passages, passing at 1:2 cells: media) before use. 
 
2.2 Reagents 
22x22 mm No. 1 Ground coverslips, 2% Bis-acrylamide and 40% acrylamide were from Fisher 
Scientific. 50% w/v Glutaraldehyde, 50% Polyethyleneimine (PEI), Oleic Acid, Rho kinase 
(ROCK1/2) inhibitor Y-27632 and Mouse anti-Vinculin antibody were from Sigma-Aldrich. 
Sulfo-SANPAH was from Thermo Scientific Pierce. Zymosan A (S. cerevisiae) BioParticles – 
Alexa Fluor 594 conjugate, Alexa Fluor 488 Phalloidin and Alexa Fluor goat anti-mouse 647 
antibody were from Life Technologies. Bovine Serum Albumin Fraction V (heat shock, fatty 
acid free) was from Roche. BODIPY 493/505 dye was from Invitrogen. Lipopolysaccharide 
(LPS) was from Invivogen. Jasplakinolide was from Santa Cruz Biotech. Rabbit anti-phospho-
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ROCK1 (Thr455/Ser456) antibody was from BioSS USA. Rabbit anti-ROCK1 antibody was 
from Cell Signaling. Mouse anti- α tubulin antibody was from eBiosciences. Goat anti-mouse 
HRP-conjugated antibody and Goat anti-rabbit HRP-conjugated antibody was from Southern 
Biotech. CpG DNA 10104 5’ – TCGTCGTTTCGTCGTTTTGTCGTT – 3’ oligonucleotides 
were from Integrated DNA Technologies. 
 
2.3 Preparation of Polyacrylamide Gel-coated Coverslips and Cell Seeding 
22x22 mm No.1 glass coverslips were activated by sequential coating with 1% 
polyethyleneimine (PEI) and 50% glutaraldehyde. After rinsing with sterile 1x PBS, coverslips 
were coated with polyacrylamide gels of the following stiffnesses - 1, 5, 20 or 100kPa (ratios 
provided in table 1).  
 
The gel layers were created (Figure 1) by sandwiching the PAA mixture between an activated 
coverslip and a Rain-X coated (hydrophobic) coverslip and exposing the resultant assembly to 
vacuum for 30-60 min (vacuum treatment time was increased for more compliant gel assemblies, 
i.e., 1 and 5kPa gels). After the gel layer had polymerized, the top hydrophobic coverslip was 
removed, the gel was coated with 0.2mg/ml Sulfo-SANPAH and exposed to 305nm UV light for 
10 min. Sulfo-SANPAH was washed off with 50mM HEPES.  
 
Gels were coated with 20ug/ml fibronectin by inverting the coverslips gel-side down in a 200ul 
bubble of 10µg/ml fibronectin overnight at 4
o
C. The fibronectin acted as a biological agent to 
assist in cellular adhesion. Each coverslip was seeded with 1x10
5
 RAW cells and incubated in a 
6-well plate at 37
0
C overnight before use.  
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Table 1: Reagent ratios to make polyacrylamide gels of given stiffness (Young’s Modulus, kPa). 
Adapted from protocol provided by Prof. Cynthia Reinhart-King, Cornell University (Huynh, 
2011). 
 
Young's 
Modulus 
(kPa) 
Volume 
Acrylamide 
(mL) 
Volume 
Bis-
acrylamide 
(mL) 
HEPES 
pH6 
(mL) 
TEMED 
(µL) 
MilliQ 
water 
(mL) 
1.0 1.50 1.00 2.6 10 13.39 
5.0 3.75 1.75 2.6 10 10.39 
20 6.00 1.90 2.6 10 7.99 
100 6.00 9.69 2.6 10 0 
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Figure 1: Schematic for generation of synthetic substrates on glass coverslips (A-B) 
Polyacrylamide gel of desired stiffness (blue) is coated on coverslips (white) and sandwiched 
with a top coverslip treated with hydrophobic product to promote even polymerization (grey). 
(C) The top coverslip is then removed and the gel surface cross-linked with protein (white) to 
facilitate macrophage adhesion. (D) Macrophages in culture media (pink) are added to the gel 
and allowed to settle (E) before fixation and staining. 
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2.4 Phagocytotic Uptake of Fluorescent Bioparticles: 
RAW cells were plated at 2x10
5
 cells/coverslip on 1, 5 and 20kPa gels or glass and incubated for 
overnight at 37
0
C. The next day, fluorescently conjugated zymosan bioparticles were added to 
each coverslip at a count of 2x10
6
/well (Multiplicity of Infection, MOI = 1:10). Coverslips were 
then incubated at 37
0
C for 30 min. Post-incubation, non-absorbed particles were quenched by 
adding trypan blue (1.2µg/ml) and washing coverslips in PBS. Cells were fixed in 3% 
formaldehyde for 20 min, washed in 1x PBS and permeabilized in 0.1% Triton X-100 in PBS for 
5 minutes.  After washing 3x in PBS, coverslips were blocked in 1% BSA in PBS for 20 
minutes. Cells were then stained with phalloidin diluted 1:40 in 1% BSA in PBS for 20 min. 
Coverslips were then washed 3x in PBS and air-dried before mounting on slides using ProLong 
Gold + DAPI mountant. 
 
2.5 Foamy Macrophage Induction 
RAW cells plated at 2x10
5
 cells/coverslip on 1, 5 and 20kPa gels and glass and were incubated 
overnight. The next day, oleic acid conjugated 8:1 to de-fatted BSA in 0.1M Tris-Cl (pH 8.0) 
(84mg oleic acid added to 3.36g BSA in 24ml 0.1M tris-Cl, vortexed and filter sterilized) was 
added to cells at a final concentration of 400uM oleate in DMEM. Coverslips with cells were 
subsequently collected at intervals of 2, 6 and 24 hours post-addition of oleate and fixed in 3% 
PFA for 10 min at RT before staining with BODIPY 493/505 (dissolved to 1ug/ml concentration 
in 150mM NaCl) for 10 min. Coverslips were then washed 3x in PBS before air-drying and 
mounting with ProLong anti-fade Gold with DAPI (Invitrogen/Molecular Probes). 
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2.6 Rho kinase/ Actin polymerization Inhibition 
RAW cells plated at 1x10
5
 cells / coverslip on 1, 5, 20 and 100kPa gels and glass were incubated 
overnight. The next day, Rho kinase inhibitor Y-27632 [(1R, 4r)-4-((R)-1-aminoethyl)-N-
(pyridin-4-yl) cyclohexanecarboxamide] was added to the cells at a concentration of 10μM for 
the rho kinase inhibition assay. For the actin polymerization inhibition assay, actin 
polymerization inducer Jasplakinolide (dissolved in DMSO) was added to the cells at a 
concentration of 0.5uM. An additional vehicle-only control was included by adding an 
equivalent volume of DMSO. Thirty minutes after addition of inhibitors, cytokine production in 
RAW cells was stimulated by the addition of either the TLR4 ligand bacterial lipopolysaccharide 
LPS (100ng/ml) or the TLR9 ligand CpG DNA (3uM). The cells were stimulated for 6 hours (Y-
27632) or 9 hours (Jasplakinolide) at 37
0
C before cytokine-containing supernatant was collected 
for analysis via TNF-ELISA. After supernatants had been collected, cells were fixed, 
permeabilized and stained to determine their cytoskeletal structure (staining for actin, vinculin 
and tubulin). 
 
2.7 Cytokine ELISA 
TNF-α production was determined using the mouse TNF-α ELISA MAX Set (BioLegend, San 
Diego, CA, USA) from supernatants of cells cultured with TLR ligands for 6-9 hours. 
Supernatants were spun down at 1400 rpm for 5 min at 4
o
C for 5 minutes to remove residual 
cells before storage at -80
o
C until use. Supernatants obtained from unstimulated cells were 
diluted 1:1 in assay diluent (1% BSA in PBS), while supernatants from cells stimulated with 
CpG DNA or LPS were diluted 1:10 in assay diluent for use in assay. Means and standard 
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deviations of sample data were calculated in Microsoft Excel 2010 and data analyzed and 
graphed in GraphPad Prism. 
 
2.8 Staining of Cells for Cytoskeletal Elements 
Cells were fixed in 3% paraformaldehyde and subsequently permeabilized with 0.1% Triton X-
100 before blocking in 1% BSA for 1 hr. Afterwards, cells were stained with primary antibodies 
against Vinculin (Sigma-Aldrich V9131 mouse anti-vinculin) or Tubulin  (eBiosciences mouse 
anti- tubulin 14-4502) (both at concentrations of 1:400 in 1% BSA in PBS) where indicated. 
Secondary staining was performed with Life Technologies Goat anti-mouse Alexa Fluor 647 
antibody (common to both anti-vinculin and anti-tubulin antibodies) at a concentration of 1:400. 
Staining with Life Technologies Alexa Fluor 488-phalloidin (1:200) was done in parallel. 
Coverslips were mounted using Life Technologies Prolong anti-fade Gold with DAPI. 
Coverslips were imaged via confocal microscopy on the Leica TCS SP5 microscope system and 
images stored in individual channels in TIFF format. Composite images were assembled in 
Adobe Photoshop. Quantitative data (cell number, size, cytoskeletal projection length) were 
obtained with the assistance of micron scale generated alongside images and averaged over 
multiple fields, slides and experiments per experimental condition. Data was analyzed in 
GraphPad Prism. 
 
2.9 Protein Immunoblotting Assay (Rho kinase Phosphorylation) 
RAW 264.7 cells were lysed in Laemmli reduced sample buffer (1% SDS, 12.5% Glycerol, 
0.005% bromophenol blue, 62.5 mM Tris pH 6.8, 1.7% beta-mercaptoethanol) by inverting 
coverslips (plated with cells) over 100ul lysis buffer bubbles for 1-2 minutes before collection in 
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1.5ml microcentrifuge tubes. Samples were boiled at 95
o
C for 5 min prior to storage at -80
o
C. 
For analysis, samples were again boiled, sonicated using probe sonication (10seconds/sample) 
and resolved on 0.8% SDS PAGE gels. Proteins were then transferred (15V, 37 min in a Bio-Rad 
Trans-Blot SD semi-dry transfer cell) to nitrocellulose membranes, and immunoblotted for 
ROCK1, phospho-ROCK1 or tubulin. The nitrocellulose membranes were blocked in TBST 
(Tris-buffered saline + 0.1% Tween-20) + 5% w/v BSA for 1 hour for the ROCK1 and phospho-
ROCK1 immunoblots and in TBST (Tris-buffered saline + 0.1% Tween-20) + 5% w/v nonfat 
dry milk overnight at 4
o
C for the tubulin immunoblot. After blocking, membrane was immersed 
in a solution of anti-ROCK1 mAb (Cell Signaling C8F7, Rabbit) or anti-phospho-ROCK1 Ab 
(BioSS bs-4063R, Rabbit) diluted 1:1000 in TBST + 5% w/v BSA (for ROCK1 and phospho-
ROCK1 respectively) overnight at 4
o
C with gentle rocking. The tubulin immunoblot was rocked 
in a solution of anti-alpha-tubulin Ab (eBiosciences 14-4502, mouse) diluted 1:1000 in TBST + 
1:20 blocking solution for 1 hour at room temperature. Membranes were then washed 3x 5min in 
TBST and incubated in secondary antibody (Goat anti-Rabbit HRP, Southern Biotech for 
ROCK1 and phospho-ROCK1 and Goat anti-Rabbit HRP, Southern Biotech for tubulin) diluted 
1:10,000 in TBST for 1 hour. After secondary antibody incubation, membranes were washed 3x 
5min in TBST and developed with Thermo Scientific Super Signal West Pico chemiluminescent 
reagent. X-ray film was used to determine presence of desired proteins (ROCK1/phospho-
ROCK1/tubulin). Densitometric analysis of protein bands to determine protein amounts was 
done in ImageJ. Quantitative data was plotted in Prism. 
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CHAPTER 3 
 
RESULTS  
3.1 Changes in substrate stiffness alter macrophage morphology and cytokine production. 
Macrophages are able to sense the stiffness of their surroundings via mechanosensing. In order to 
determine the effect of substrate stiffness on macrophage morphology, specifically in the 
distribution of the actin filaments of the cytoskeleton, I plated primary murine bone marrow-
derived macrophages on 20kPa gels on 22x22mm glass coverslips or glass coverslips alone and 
visualized their actin cytoskeletal structure by staining the plated cells with Alexa 488-
conjugated phalloidin and subsequently imaging them via fluorescent microscopy. On the 20kPa 
gel, macrophages adopted a small footprint and bright green actin rings, regions of high actin 
density (Figure 2, right). In contrast, on glass, cells were spread out over a large area and 
exhibited two-dimensional actin meshes called lamellipodia. The actin rings were replaced by 
irregular patches of high actin density in cells plated on glass (shown in inset box, Figure 2, 
left). The morphological characteristics of the cells are summarized in Table 2. These findings 
are consistent with a previous study performed with alveolar macrophages (Fereol, 2006). 
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Figure 2: Macrophage morphology changes across substrates with different modulus of 
elasticity. Primary mouse macrophages were plated overnight on glass or 20kPa gels. After 
fixation and permeabilization, cells were stained with phalloidin-Alexa 488 (Green, showing 
actin cytoskeleton) and mounted using ProLong AntiFade Gold with DAPI (Blue, staining 
double-stranded DNA and denoting the nucleus). Scale bars = 10 µm. Inset boxes in the bottom 
right corner of each field are 2x magnification views of the regions enclosed in the white square 
of the respective image). Images were acquired on a Leica SP5 confocal microscope and 
compiled in Photoshop. Images are representative of 5 independent experiments. 
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Table 2: Characterization of primary bone marrow macrophages plated on 20kPa gels or glass. 
Numbers are representative of 50 cells imaged across four fields per slide, two slides per 
experimental condition over 5 independent experiments. 
 
Substrate type 
 
Average 
Nucleus size 
(μm) 
Average 
Cell size 
(μm) Actin ring? 
Number of Actin 
projections/cell, type 
20kPa 10 20 yes 
 
15.22±0.33, filopodia 
Glass 10 30 No 
 
35.14±0.97 filopodia, 
lamellipodia 
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Atherosclerotic plaques contain regions of various stiffnesses, and contain macrophage 
populations that have different inflammatory profiles. To determine whether the variations in 
mechanical stiffness within atherosclerotic plaque affects macrophage inflammatory profiles, the 
amount of proinflammatory cytokine produced by macrophages was measured in supernatants of 
cells plated on rigid and elastic surfaces. Primary bone marrow-derived macrophages were plated 
on 20 kPa gels or on glass (50 gPa) coated with BSA or poly-l-lysine (PLL) and then stimulated 
with media alone or CpG DNA 10104 (3 µM). CpG DNA oligonucleotides are a common motif 
in prokaryotic DNA and are a potent inducer of macrophage activation and subsequent 
proinflammatory cytokine production (Ramirez-Ortiz, 2008). Cells plated on 20kPa gels had 
higher basal levels of TNF-α secretion than those plated on glass (Figure 3A), and the TNF-α 
secretion in response to stimulation with CpG DNA was higher for cells plated on 20kPa gels vs. 
glass as well. The TNF-α response in cells on the compliant gel substrate was independent of 
biomatrix chemistry, being higher irrespective of whether the substrates were coated with BSA 
or PLL. Calculation of the fold induction revealed that cells plated on the 20kPa gel had a 
smaller increase in TNF-α secretion than cells plated on glass when stimulated with CpG DNA 
(Figure 3B). Together, these data suggest that substrate stiffness affects both macrophage 
morphology and inflammatory response, but further studies will be required which would 
include normalizing the response for cell numbers via qPCR analysis. Increased background seen 
in cells on gel may be due to altered sensitivity to stimuli, which may be studied by evaluating a 
CpG DNA dose response. 
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Figure 3: Proinflammatory cytokine production in macrophages increases with increase in 
substrate stiffness. (A) Primary bone marrow-derived macrophages were plated on 20kPa 
polyacrylamide gel or glass (50gPa), coated with either BSA or PLL as the biologic surface 
agent and stimulated with media or CpG DNA oligonucleotides. Supernatants were collected 
after 6 hours of stimulation and TNF-α was quantitated via ELISA (commercial kit). (B) Fold 
increase in TNF response of cells. Representative of three independent experiments. **: p<0.01, 
*: p<0.05, unpaired t-test. 
A 
B 
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3.2 Increase in substrate stiffness promotes macrophage phagocytotic activity 
Phagocytosis is the key defining function of macrophages. We next determined whether the 
changes in macrophage morphology and proinflammatory cytokine production were 
accompanied by changes in the cells’ ability to perform phagocytosis. Primary bone marrow-
derived macrophages plated on gels of varying stiffnesses were incubated with Saccharomyces 
cerevisiae zymosan bioparticles. Fluorescent imaging (Figure 4A) revealed that the 
macrophages plated on more compliant gels had a lower phagocytotic capacity. Macrophages 
plated on 20 kPa gels had a higher percentage of cells that phagocytosed bioparticles than those 
plated on 5 kPa gels (Figure 4B). Cells plated on glass phagocytosed 9±2.2 particles/cell, 
whereas cells plated on 5kPa and 20kPa gels engulfed 1.35±0.9 and 2.5±1.14 zymosan 
particles/cell respectively (Figure 4C). This demonstrates that substrate stiffness also affects 
macrophage phagocytosis. 
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Figure 4: Increase in substrate rigidity leads to increase in bioparticle phagocytosis. (A) 
Primary murine bone marrow-derived macrophages plated on either glass coverslips or 5kPa or 
20kPa PAA gels on coverslips were exposed to Life Technologies Alexa Fluor 594-conjugated 
Zymosan A (Saccharomyces cerevisiae) particles (red) and stained with Alexa Flour 488-
phalloidin (actin cytoskeleton, green) and DAPI (nuclei, blue). Images were acquired on a Leica 
SP5 confocal microscope at 40x magnification, complied in Photoshop and are representative of 
three independent experiments. (B) Fraction of total number of cells that have phagocytosed 
bioparticles. (C) Average # of bioparticles per cell, each cell having phagocytosed minimum one 
bioparticle. Numbers are calculated from an average of ~100 cells measured across two fields per 
slide, two slides per experiment over three independent experiments. Statistical significance 
determined in GraphPad Prism via one-way ANOVA with alpha = 5%. **** = P≤ 0.0001, ns = 
P>0.05. Scale bars = 20 µm. 
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3.3 Lipid uptake and clearance rates are affected by substrate stiffness 
Lipid handling and clearance is one of the primary tasks of macrophages in regulation of 
atherosclerosis. Therefore, we next evaluated lipid uptake and clearance by macrophages plated 
on substrates of varying stiffness. Oleate was added to primary bone marrow-derived 
macrophages plated on 5 kPa or 20 kPa gels or glass, coated with 0.1% w/v BSA at a final 
concentration of 400 μM, and the cells were collected after 2, 6 or 24 hours (Figure 5E). Lipid 
uptake was observed as early as two hours in cells grown on more compliant gels (5kPa), but 
lipid droplets were not observed until later on stiffer gels (20kPa) or glass (Figure 5A). Cells 
grown on 5kPa gels retained a larger number of lipid droplets than those plated on glass after 24 
hours (Figure 5B). Furthermore, more lipid droplets were observed per cell when cells were 
grown on compliant gels (Figure 5C). Although the number of droplets was less at 24 hours than 
at 6 hours for cells grown on 5kPa gels, many of the droplets appeared larger in size (Figure 5B, 
5D). These results indicate that lipid uptake and retention is increased in macrophages plated on 
more compliant substrates. 
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Figure 5: Increased substance stiffness leads to lower lipid retention. Primary murine bone 
marrow macrophages were exposed to oleate and were collected at the following timepoints: 0 
hours (before addition of oleate), 2 hours, 6 hours and 24 hours. Cells were stained for lipid 
using BODIPY 493/505 dye (Green) and nuclei with DAPI (blue). Coverslips were imaged on a 
Leica SP5 confocal microscope. White arrows point to lipid droplets. Images are representative 
of three independent experiments. (A) Green-stained lipid droplets were visible on 5kPa gels 
after 2 hours but not on glass. (B) Lipid droplets were still present in cells on 5kPa gels after 24 
hours but not on glass. (C)Statistical analysis of lipid droplets in cells, showing average number 
of lipid droplets per cell, across 5kPa, 20kPa and glass over four collection times. (D) Average 
number of small (<1 um dia.) and large (>1um dia.) lipid droplets per cell, across 5kPa and 
20kPa gels and glass, over time, showing relative rates of clearance of smaller lipid droplets 
versus larger volumes in cells plated on substrates of varying stiffness. Data represents an 
average of ~200 cells imaged across two slides per stiffness per experiment, over three 
experiments. Statistical significance was determined in GraphPad Prism via 2-way ANOVA 
using the Tukey method, with alpha = 5%. **** = P≤ 0.0001, ns = P > 0.05 (E) Representative 
images of cells plated on the three substrate types and imaged at each of the 4 collection 
timepoints. 
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Figure 5 (Continued) 
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3.4 Rho kinase inhibitor affects cell morphology and TNF-α production in activated 
macrophages. 
Rho kinases (ROCK) are known to mediate mechanosensing pathways and have been found to 
play a critical role in cardiovascular disease (Loirand, 2006; Shimokawa, 2007, Zhou, 2011). To 
determine whether ROCK participated in mechanosensing and the inflammatory response, we 
next evaluated the effect of ROCK inhibitors on macrophage morphology and TNF-
production. RAW264.7 macrophages were pretreated with a rho kinase inhibitor Y-27632 that 
blocks the activity of both ROCK1 and ROCK2 (Uehata, 1997), and stimulated with CpG DNA 
or LPS. Cytoskeletal components actin, tubulin and vinculin were resolved for imaging via 
fluorescent staining. On softer matrices (1 and 5 kPa - Figure 6B, 6C), the RAW cells adopted a 
small circular footprint, as visualized by a prominent but thin actin ‘ring’ around the nucleus 
whereas on stiffer matrices (Glass, 20kPa and 100kPa – Figure 6A, 6D, 6E), irregular two-
dimensional meshes (lamellipodia) were observed due to the extension of the cytoskeletal 
structure. Pretreatment with Y-27632 led to an increase in the size of cells plated on the stiff 
glass (Figure 6A). Cells stimulated with CpG DNA or LPS were also imaged. Cells plated on 
stiffer matrices had extensive distribution of tubulin compared to those plated on more compliant 
matrices, reflecting the increase in cell footprint. This is in support of the expanding of the 
macrophages on stiff substrates as seen by the increase in the area covered by the actin filaments. 
Microtubule organizing centers were visible as spindles of tubulin filaments. Vinculin 
distribution in cells plated on gels and glass was punctate, corresponding to interactions between 
vinculin and the actin cytoskeleton which lead to formation of focal adhesion loci indicative of 
mechanosensing. 
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Figure 6: Inhibition of Rho kinases induces formation of filopodia and lamellipodia in 
RAW macrophages plated on gels and glass. Comparison of RAW 264.7 cells plated on (A) 
Glass, (B) 1kPa, (C) 5kPa, (D) 20kPa or (E) 100kPa gels with or without ROCK inhibitor Y-
27632. Cells are stained for nuclei (DAPI, blue), actin (Alexa Fluor 488 phalloidin, green) and 
tubulin (Alexa Fluor 647, red) or vinculin (Alexa Fluor 647, red). Scale bars = 10 μm. 
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B 
Figure 6 (Continued) 
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C 
Figure 6 (Continued) 
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D 
Figure 6 (Continued) 
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E 
Figure 6 (Continued) 
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Macrophages pretreated with Y-27632 displayed a diffuse vinculin distribution, suggesting a loss 
of focal adhesion loci. Cells plated on 1kPa gel (Figure 6B) were the exception, showing more 
focal adhesion loci post-ROCK inhibition than without.  
 
I next determined if inhibiting ROCKs affected macrophage TNF-α production in response to 
CpG DNA or LPS (Figure 7). TNF-α production was significant in cells plated on glass (Figure 
7A), 20kPa gels (Figure 7C) and 1kPa gels (Figure 7E). Pretreatment with Y-27632 made a 
statistically significant difference in TNF-α production in response to CpG DNA or LPS 
stimulation in cases where the TNF-α secretion was significant. Y-27632 pretreatment lowered 
TNF-α response to CpG DNA stimulus in macrophages plated on 1kPa, 20kPa gels and glass. 
LPS response was significant only in the case of cells plated on glass, where Y-27632 
pretreatment increased TNF-α production on stimulation.  
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Figure 7: Proinflammatory cytokine production in macrophages is affected by 
pretreatment with rho kinase inhibitors. RAW 264.7 cells were plated on (A-E) Glass or 1, 5, 
20 and 100kPa gels overnight and stimulated with CpG DNA or LPS, with or without pre-
treatment with 10uM of ROCK inhibitor Y-27632 (30 min prior to stimulation) for 6 hours. 
Supernatants were collected after 6 hours of stimulation. Data was collected across two 
individual experiments consisting of 1) Glass, 1kPa and 5kPa gels and 2) Glass, 20kPa and 
100kPa gels. Statistical significance was determined using the Holm-Sidak method in two-way 
ANOVA in GraphPad Prism, with alpha = %. ns = P > 0.5, ** = P ≤ 0.01, *** = P ≤ 0.001 
A B 
C D 
E 
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3.5 Inhibition of actin filament re-polymerization does not significantly affect TNF-α 
production by activated macrophages. 
Mechanosensing requires reconfiguration of the actin cytoskeleton for formation of adhesion and 
mechanotransduction contact points (Leung, 1996). To evaluate how cytoskeletal rearrangement 
affects the inflammatory response in macrophages, I tested the effect of actin polymerization 
inhibition on macrophage proinflammatory cytokine (TNF-α) production. In similar fashion to 
the ROCK inhibition experiment, RAW 264.7 cells were pre-treated with the actin 
polymerization inducer Jasplakinolide prior to stimulation with CpG DNA or LPS for nine hours. 
Jasplakinolide is a macrocyclic peptide natural product from the marine sponge Jaspis 
johnstoni that induces the polymerization of actin into filaments (F-actin) (Scott, 1988). It 
competitively binds to F-actin and irreversibly stabilizes it to form filaments (Bubb, 1994).  
Treatment of macrophages with Jasplakinolide would therefore provide a means to study the 
effect of loss of cytoskeletal reorganization capability on macrophage activation by comparing 
levels of inflammatory cytokine production. Analysis of supernatant from stimulated cells 
(Figure 8A-E) was inconclusive, as no significant data could be obtained. While cells plated on 
glass (Figure 8A) and 20kPa gels (Figure 8C) had a strong response in comparison to 100kPa 
(Figure 8B), 5kPa (Figure 8D) and 1kPa gels (Figure 8E), basal TNF secretion levels were also 
elevated, in comparison to basal response by cells in Figure 7. Jasplakinolide pre-treatment did 
have a statistically significant effect on TNF-α production in response to CpG DNA stimulation 
when compared to pre-treatment with DMSO (vehicle) in the case of 20kPa gels (Figure 8C). In 
the case of LPS, Jasplakinolide pre-treatment significantly reduced TNF-α production in cells 
plated on glass or 20kPa gels (Figure 8C, 8E).  
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Figure 8: Effect of actin repolymerization inhibitor Jasplakinolide pretreatment on 
proinflammatory cytokine production in macrophages. RAW 264.7 cells were plated on 1, 5, 
20 or 100kPa gels or glass overnight and stimulated with CpG DNA or LPS (with unstimulated 
controls) following pretreatment with DMSO vehicle or 0.5 uM Jasplakinolide dissolved in 
DMSO or un-pretreated control (pre-treatment done 30 min prior to stimulation). Supernatants 
were collected after 9 hours of stimulation and TNF-α was quantitated via ELISA (commercial 
kit). Data representative of two independent experiments. Statistical significance was determined 
using the Holm-Sidak method in two-way ANOVA in GraphPad Prism, with alpha = 5%. ns: p > 
0.5, *: p < 0.05, ****: p < 0.0001. 
A B 
C D 
E 
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3.6 Increase in substrate stiffness increases Rho kinase expression in macrophages. 
ROCKs induce the formation of actin stress fibers and focal adhesions by phosphorylating the 
myosin light chains (MLC) (Leung, 1996), an act in which the ROCKs become phosphorylated. 
To determine whether mechanosensing-driven rearrangement of the actin cytoskeleton requires 
ROCK, I assessed the level of ROCK expression and phosphorylation in RAW 264.7 
macrophages plated on 1, 5, 20 or 100kPa gels or glass coverslips via Western Blot. 
Immunoblotting of lysine with antibodies against ROCK1 and phospho-ROCK1 revealed an 
increase in ROCK1 protein in cells plated on stiffer substrates (Figure 9A). pROCK1 detection 
was insufficient to draw conclusions about degree of ROCK1 phosphorylation in the cells. 
Densitometry analysis of the ROCK1 immunoblot bands normalized to α-tubulin expression 
levels (Figure 9B) showed that ROCK1 expression in cells appeared to increase with increase in 
substrate stiffness (with the exception of cells plated on 100kPa gel). Densitometric analysis of 
the degree of ROCK1 phosphorylation (pROCK1 intensity/ ROCK1 intensity) (Figure 9C) was 
inconclusive due to the low detection of pROCK1 in the immunoblot. Therefore, ROCK1 
expression in macrophages may increase with increase in substrate stiffness, but whether 
ROCK1 phosphorylation (and hence activation) increases as well is as yet unclear.
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Figure 9: ROCK phosphorylation in RAW 264.7 macrophages increases with 
increase in substrate stiffness. (A) RAW 264.7 cells were incubated overnight on 1, 
5, 20, or 100 kPa PAA gels or glass. Cells were lysed in lysis buffer and lysate probed 
for ROCK1 and phospho-ROCK1 (Cell Signaling C8F7 Rabbit anti-ROCK1 antibody 
and BioSS bs-4063R Rabbit anti-phospho-ROCK1 antibody respectively, Southern 
Biotech Goat anti-Rabbit HRP secondary antibody) as well as for tubulin 
(eBiosciences 14-4502 anti-alpha tubulin). (B) Immunoreactive band intensity of 
ROCK1 was quantified and normalized to that of tubulin loading control in ImageJ. 
(C) Degree of ROCK1 phosphorylation (pROCK1/ROCK1 band intensity) was 
quantified in ImageJ and plotted in GraphPad Prism.
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CHAPTER 4 
 
DISCUSSION 
4.1 Summary of findings 
Macrophages are one of the primary driving factors in the progression of atherosclerotic plaques.  
Lipid buildup in the subendothelial regions of arteries ‘activates’ the overlying endothelium, 
leading to recruitment of blood-borne monocytes to the accumulation site. Normally, monocytes 
then differentiate into macrophages that secrete the anti-inflammatory cytokine IL-10 and clear 
the lipids and apoptotic cells accumulated in the region.  If the individual has multiple factors 
predisposing them for atherosclerosis; however, the lipid buildup becomes in excess of the 
macrophages’ capacity to clear them. At this point the macrophages begin to take up lipid in 
excess of their capacity to clear it and turn into macrophage foam cells, which accumulate in the 
buildup site and eventually undergo apoptosis. Failure of other macrophages to efficiently clear 
these apoptotic cells (efferocytosis) leads to secondary necrotic death, which is highly 
inflammatory and promotes development of a necrotic core. While normal efferocytosis would 
promote resolution of inflammation via production of IL-10 and TGF-β by macrophages, 
impaired efferocytosis exacerbates inflammation due to macrophages that respond to toxic lipids 
and apoptotic cell debris by producing TNF-α and other proinflammatory cytokines. As plaque 
development progresses, the necrotic core increases in size while the overlying fibrous cap thins 
out due to degradation by matrix metalloproteases (MMPs). These thin caps are unstable and can 
rupture leading to thrombotic events (Nagase, 2006; Newby, 2007; Chowdhary, 2006). 
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We can thus see that macrophages play multiple vital roles in atherogenesis, and there are 
therefore multiple pathways that could be targeted to interrupt the inflammatory cycle (e.g., 
monocyte recruitment, macrophage polarization, efferocytotic activity etc.). Development of 
effective therapies necessitates proper investigation and definition of the role(s) played by 
macrophages at each step of atherogenesis. Existing approaches such as transcriptome analysis 
have provided multiple differentially regulated genes in atherosclerosis, but the cellular- and 
tissue-level complexity of an atherosclerotic lesion lead to difficulties in proper mapping of gene 
expression profiles to the appropriate cells within the tissues. While technologies such as laser 
capture microdissection allow isolation of individual parts of the lesion such as the necrotic core 
and the fibrous cap and help partially overcome the mapping problem, there is still a need to be 
able to control and mimic the tissues’ mechanical properties, which can vary from very 
compliant (necrotic core) to very stiff (fibrous cap). Since growth environment stiffness has been 
known to play a role in fate determination of mesenchymal stem cells during differentiation 
(Engler, 2006), there is a strong need to determine the relative role of macrophage 
mechanosensing in the regulation of atherosclerosis. In this thesis, I examine the effect of 
substrate stiffness on macrophage function: inflammatory cytokine (TNF-α) production, 
microbial phagocytosis and lipid uptake and clearance. I also examine the effects of inhibition of 
rho kinases (which play an important role in mediation of mechanosensing pathways) and 
inhibition of actin polymerization on cytokine production profiles. 
 
The first task was to examine the effect of compliant vs. stiff substrates on macrophage 
morphology and cytokine production. Previous research had been conducted detailing the effect 
of substrate stiffness on different cell types such as murine aortic smooth muscle cells (Engler 
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2004), alveolar macrophages (Fereol, 2006) and primary bone marrow-derived macrophages 
(Blakney, 2012).  To develop a proper understanding of the effects of substrate stiffness on 
macrophages’ role in atherosclerosis progression, it was necessary to develop a model to study 
monocyte-derived macrophages in vitro that would accurately mimic the range of tissue 
stiffnesses encountered in atherosclerotic lesions. The polyacrylamide gel model used in my 
studies is highly tunable and versatile (as the stiffness of the gel can be adjusted to defined 
values by changing the acrylamide/bisacrylamide ratio to predefined values – Pelham, 1997) , 
allowing me to cover the spectrum of stiffness encountered in atherosclerosis with minimal 
adjustment. However, the polyacrylamide gel model has many limitations: it is not a biological 
material and thus must be functionalized and coated with a biological matrix to promote cell 
adhesion, limiting its usefulness to 2-dimensional studies which only roughly approximate in 
vivo conditions. The polyacrylamide matrix is also very hygroscopic in nature, and is thus prone 
to swelling in aqueous conditions which can change the actual stiffness of the gel and exert 
additional undesirable mechanical stress on cells. Alternatives to the polyacrylamide gel system 
include use of collagen-based, gels which are biological in nature and provide better approximate 
biological conditions. The most ideal choice would be matrigel, which is a gelatinous protein 
mixture of laminin, entactin and collagen secreted by Engelbreth-Holm-Swarm mouse sarcoma 
cells (Hughes, 2010). This mixture closely resembles the extracellular matrix of many living 
tissues and acts as a viable culture medium when perfused with the appropriate nutrients. 
Additionally, its mechanical properties are highly tunable and it is capable of self-assembly at 
body temperature (37
0
C) into solid form but is a liquid at lower storage temperatures (4
0
C). 
However, since the matrigel is composed entirely of ECM proteins, substrate stiffness cannot be 
uncoupled from ECM protein concentration. Cells form mechanosensing interactions via 
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integrin-mediated adhesion to ECM protein; therefore measuring the effect of substrate stiffness 
on macrophage behavior independent of adhesion strength will be difficult. 
 
Here, I have shown that cells plated on softer gels (20kPa) secrete higher basal amounts of the 
proinflammatory cytokine TNF-α , as well as upon stimulation with CpG DNA (simulating the 
pro-inflammatory effect of cellular debris present in advanced atherosclerotic plaques) than cells 
plated on stiff glass, although the final fold increase from basal levels is lower. This finding 
supports a model where macrophages that are exposed to the compliant lipid-rich environment of 
atherosclerotic lesions are more likely to produce pro-inflammatory cytokines when they come 
into contact with apoptotic cells and inflammatory products of apoptosis in the lesion, fueling 
further inflammation. 
 
Comparison of phagocytotic activity across cells plated on gels of varying stiffnesses revealed 
that cells plated on softer substrates exhibited lower rates of bioparticle phagocytosis, possibly 
due to the increased surface area of cells plated on stiffer substrates increasing the chance of 
encountering a bioparticle. While microbial phagocytosis in macrophages is different from 
apoptotic cell phagocytosis (highly proinflammatory compared to anti-inflammatory), this is still 
strong evidence implicating that macrophage response to physical substrate stiffness plays a role 
in regulation of macrophage phagocytosis.  
 
Lipid uptake and clearance were also affected by substrate stiffness. Oleate uptake was increased 
in cells plated on softer gels and occurred earlier than in cells plated on stiffer gels and glass. 
Lipid clearance during the 24-hour observation period was adversely affected on softer gels, with 
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significantly higher volume of lipid being retained after 24 hours. This suggests that lipid loading 
is accelerated in early atherosclerotic fatty streaks and promotes foam cell formation, while in 
advanced atherosclerotic lesions the stiffness of the fibrotic cap discourages lipid uptake in 
macrophages and causes lipid accumulation in the lesion core. 
 
The observed effects of substrate stiffness on macrophage morphology and cytokine production 
led me to investigate the effects of disruption of mechanosensing on macrophages. Rho kinases 
(ROCK 1 & 2) play a vital role in mediation of mechanosensing pathways and were chosen as 
the targets. Pretreatment of RAW264.7 cells with the pharmacological ROCK inhibitor Y-27632 
followed by stimulation with CpG DNA or LPS reduced the sensitivity of the RAW cells to CpG 
DNA stimulation when the cells were plated on glass or 20kPa/1kPa gels (response from cells on 
other gels was inconclusive). Response to LPS stimulus was significantly different (elevated) in 
the case of cells plated on glass only. Inhibition of ROCK appeared to increase the cell size on 
higher stiffnesses. This suggests that ROCK-associated mechanosensing of substrate stiffness 
plays a role in determining the magnitude of pro-inflammatory response in macrophages, in a 
manner specific to the type of inflammatory stimulus presented to the macrophages. Inhibition of 
ROCK activity may therefore retard the substrate stiffness-associated changes in macrophage 
inflammatory profiles. 
 
An experiment was designed to test the effect of an actin repolymerization inhibitor 
Jasplakinolide on mechanosensing. However, pretreatment of RAW 264.7 cells with 
Jasplakinolide followed by stimulation with CpG DNA or LPS did not provide sufficient data to 
determine whether TNF-α production is affected by inhibition of actin repolymerization, other 
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than a decrease in TNF production in cells on 20kPa gels when stimulated with either CpG or 
LPS, or in cells on glass stimulated with LPS. While my results were inconclusive, further 
investigation may reveal the effect of inhibiting actin cytoskeletal rearrangement in response to 
changes in substrate stiffness on macrophage inflammatory response. 
 
I also analyzed the level of expression and degree of phosphorylation (signifying activation) of 
ROCK1 in macrophages plated on the various substrates (1, 5, 20 and 100 kPa gels and glass) by 
resolving the whole cell lysate of the plated cells via SDS-PAGE and immunoblotting for 
ROCK1 in its phosphorylated and unphosphorylated forms. It was found that ROCK1 expression 
increased with increase in substrate stiffness, but immunoblot of phospho-ROCK1 was 
inconclusive; therefore effect of stiffness on ROCK1 activity cannot yet be defined. 
 
4.2 Macrophages sense the stiffness of their growth substrate and modulate proinflammatory 
cytokine production accordingly. 
Primary bone marrow-derived macrophages plated on compliant (20kPa) gels adopted a smaller 
footprint with short, singular projections while macrophages on glass occupied a larger footprint 
and had longer, 2-dimensional projections (Figure 2). Macrophages on compliant gels also had 
higher background levels of TNF-α, and when stimulated with CpG DNA, produced 
significantly more TNF-α than macrophages on highly rigid glass (Figure 3), a finding that is 
consistent with a previous study in murine bone marrow-derived macrophages plated on 
polyethylene glycol (PEG-RGD) hydrogels (Blakney, 2012) where relative TNF-α gene 
expression levels were higher in cells plated on more compliant gels. Fold increase in TNF 
production upon CpG stimulation was lower in cells plated on gel, due to the relatively high 
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basal response. The response was specific for gel stiffness and not biomatrix chemistry, since the 
response of cells on 20 kPa gels crosslinked with BSA or poly-L lysine was statistically 
significantly greater than on the corresponding BSA/PLL-coated glass coverslips (p<.001). 
These results support previously published studies on other macrophage types and provide 
evidence for substrate stiffness playing an important role in modulation of proinflammatory 
cytokine production via mechanosensing. The findings support the idea that macrophages 
existing in lipid- and cellular debris-rich atherosclerotic lesions contribute to inflammation, as 
they are likely to produce more proinflammatory cytokine in a compliant environment. 
 
4.3 Macrophage bacterial phagocytosis increases with substrate stiffness. 
The observed reduction in macrophage footprint and increase in proinflammatory cytokine 
production on more compliant substrates correlated with reduced microbial phagocytosis.  
Importantly, the alterations in phagocytotic activity were not unique to the 20kPa gels and were 
also observed on even more compliant 5kPa gels – effectively, microbial phagocytosis was 
maximized on glass compared to the limited uptake when on gels, independent of bioparticle 
dosage (Figure 4). This increase may also be due to the increased surface area presented by the 
macrophages plated on glass, which would increase the chance of encountering and engulfing the 
bioparticle. This increase in phagocytotic activity may help explain to the observed lower 
efferocytotic efficiency of macrophages in the compliant necrotic core of advanced lesions, 
leading to buildup of apoptotic cells and toxic cellular debris, which leads to further 
inflammation. It is worth noting that phagocytosis of bacteria and yeast is highly 
proinflammatory and relies on different receptors than phagocytosis of apoptotic cells, which is 
anti-inflammatory (Huynh, 2002). Therefore, loss of efferocytotic activity in the lesion core 
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promotes inflammation through both buildup of proinflammatory cellular components and loss 
of anti-inflammatory cytokine. These data strongly implicate macrophages response to physical 
stiffness as a mechanism for regulating phagocytosis and point to a potential therapeutic avenue 
for controlling atheroprogression via modulation of phagocytosis. Further research would 
include the direct study of efferocytotic activity in primary bone marrow-derived macrophages 
plated on gels and incubated with apoptotic cells, analyzing efferocytotic efficiency and cytokine 
production variability across substrate stiffness, dosage levels and incubation periods.  
 
4.4 Macrophage lipid uptake is dependent on substrate stiffness. 
Primary bone marrow-derived macrophages plated on 20kPa gels or glass developed lipid 
droplets at six hours and very few lipid droplets were still detectable by 24 hours. In contrast, 
macrophages plated on 5kPa gels were loaded with lipid droplets by 2 hours (Figure 5A) and 
still contained significant numbers of lipid droplets at 24 hours (Figure 5B). After 2 hours, small 
lipid droplets (<2 µm dia.) were visible in the cells, but by 24 hours, large lipid droplets (>5 µm 
dia.) were visible (Figure 5B). Statistical analysis of lipid droplet counts across the three 
substrates over time showed that lipid uptake and retention was indeed higher in cells plated on 
the softest (5kPa) substrate (Figure 5C, D). These data suggest that lipid uptake and efflux are 
regulated by mechanosensing, such that macrophages grown on compliant matrices take up more 
quickly, and retain larger volume of lipids, than those grown on stiffer substrates.  It should be 
kept in mind that uptake of normal lipids is a beneficial function of macrophages while uptake 
and storage of oxidized lipids results in foam cells and progression of atherosclerosis. This 
supports a model where macrophages alighting on healthy, compliant arterial tissue have 
efficient lipid uptake but get overloaded with lipid in the lipid-rich fatty streak tissue of early 
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atherosclerotic lesions, forming large foam cells. In later stages of the lesion, the stiffness of the 
fibrotic cap lowers lipid uptake in neighboring macrophages, leading to increased lipid buildup 
in the lesion core. In addition, decrease in free cholesterol efflux or ACAT function in lesional 
macrophages (Yvan-Charvet, 2007; Zhu, 2008; Tang, 2009) may lead to macrophage death due 
to cholesterol-induced toxicity and subsequent increase in apoptotic cell numbers, forming the 
necrotic core seen in late-stage plaques.   
 
4.5 Inhibition of rho kinases affects cell morphology and TNF-α production. 
Rho kinases (ROCK) are downstream effectors of the small GTPase Rho and phosphorylate LIM 
kinase (which in turn phosphorylates cofilin and inactivates its ability to inhibit actin 
depolymerization) (Maekawa, 1999) as well as myosin light chain kinase (increasing myosin II 
ATPase activity and shorten actin fibers) (Wang, 2009). ROCKs have been established in 
literature as playing a role in macrophage migration in three-dimensional environments (Van 
Goethem, 2010), efferocytosis (Tosello-Trampont, 2003) and foam cell formation (Wang, 2008). 
This supports the idea that ROCKs are involved in the regulation of pro-atherogenic macrophage 
functions via regulation of macrophage mechanosensing. Efferocytosis is enhanced when RhoA-
mediated signaling is inhibited and inhibited upon overexpression of constitutively active RhoA 
(Tosello-Trampont, 2003). In bone marrow-derived macrophages, ROCK1 is necessary for 
movement into atherosclerotic lesions and for foam cell formation (Wang, 2008). ROCK 
regulates several cytoskeletal processes including cytoskeletal tethering, which is the major 
mechanism for mechanotransduction in response to substrate stiffness, and is thus a good 
candidate for studies examining the role of mechanosensing in proatherogenic functions of 
macrophages. The chemical compound Y-27632 ((1R, 4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl) 
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cyclohexanecarboxamide) inhibits p160ROCK (Uehata, 1997) and is thus an ideal biochemical 
tool to study ROCK. In this study, it was found that pretreatment of RAW264.7 cells with Y-
27632 resulted in an increase in cell size in macrophages plated on the stiffer substrates (Figure 
6). This may be explained by the loss of mechanosensing in the cells leading to formation of new 
cytoskeletal projections to reacquire mechanical cues from the environment. Resolution of 
vinculin protein (involved in the formation of focal adhesion plaques that link integrin adhesion 
molecules to the actin cytoskeleton) in the cells reveals a loss of the discrete punctate distribution 
of vinculin in the Y-27632-treated cells plated on glass (Figure 6A), suggesting that cellular 
adhesion and thus mechanosensing has been successfully disrupted. This disruption is not 
consistent, as vinculin distribution was not diffused in the case of other substrates (in the case of 
1kPa gel (Figure 6B), the vinculin distribution is enhanced, suggesting that mechanosensing is 
not disrupted). The tubulin network in cells is unaffected by exposure to Y-27632 except for the 
formation of microtubule-organizing centers (MTOCs) prominently visible in the cells plated on 
softer gels (1kPa and 5kPa) (Figure 6A). This may be explained by the fact that Y-27632-
induced loss of focal adhesion bodies affects cellular adhesion most adversely in cells on 
compliant gels, due to the overall smaller number of existing adhesion points compared to stiffer 
gels making the loss a greater percentage of the total. The formation of the MTOC is the event 
that initiates de novo formation of additional microtubules to restore structural rigidity and 
consequently recover cellular adhesion. These changes were not observed in all cells plated on 
the same substrate and were not found in all substrates, suggesting that ROCK inhibition may not 
have been universal. There is therefore a need to find the optimal conditions for comprehensive 
ROCK inhibition by Y-27632.  
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ELISA analysis of TNF-α production in the RAW cells after Y-27632 pretreatment and 
stimulation with CpG DNA or LPS (Figure 7) did not show any significant change in TNF-α 
compared to cells untreated with Y-27632 other than in the conditions where TNF-α production 
was already high (in which case ROCK inhibition reduced the TNF-α response to CpG DNA 
stimulation and increased the LPS response). This could potentially be due to the inflammatory 
stimulus being too low to provoke a significant response. Alternatively, the RAW264.7 cells 
(which were chosen for this and other experiments rather than primary macrophages due to time 
and logistical constraints) being a differentiated, immortalized cell line and therefore not as 
sensitive to environmental stiffness variation and inflammatory stimulus could contribute to the 
seeming insensitivity to Y-27632 pretreatment. Both theories can be tested in the future by using 
bone marrow-derived macrophage populations instead and administering the ROCK inhibitor 
earlier in the process of adherence/acclimatization to the substrate, as well as ensuring that the 
population of available cells as well as the dose of inflammatory stimulant is sufficiently large to 
generate a distinct response. The difference in CpG and LPS response may be due to the fact that 
ROCK is a downstream effector of RhoA, which is a target for rapid activation by LPS (Chen, 
2002) in order to regulate NF-κB activation. Stimulus-dependent complex formation between 
active RhoA and the novel protein kinase Cζ (PKCζ) was observed to be essential for regulating 
NF-κB activation (Chen, 2005). LPS-induced activation of RhoA, in the absence of the 
downstream target ROCK, may cause increased NF-κB activation and TNF-α production, 
explaining the increase in TNF production in macrophages treated with the ROCK inhibitor. 
While the effect of CpG DNA stimulation of TLR9 in lesional macrophages has not been fully 
defined, TLR9
-/-
 mice recover better from a transverse aortic constriction model of heart failure 
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(Oka, 2012). It is possible that TLR9 plays an atheroprotective role similar to TLR7, whose 
deficiency enhances lesion development in ApoE-deficient mice (Salagianni, 2012). 
 
TNF-α production in cells plated on 20kPa gels was significantly higher than that in cells plated 
on all other gels, distinct from the trend of increased TNF-α production on more compliant gels. 
This anomaly may be correlated to the increased swelling observed in 20kPa gels compared to 1, 
5 and 100kPa gels – the additional shear stress and strain exerted on the cells due to the swelling 
could be a potential cause of cytokine release in response to stress, as it has been previously 
reported that mechanical stress induces TNF-α production in the monocyte-like cell line THP-1 
(Kim H.G, 2008). The cause of the swelling is unknown, but may be due to the specific ratio of 
acrylamide and bisacrylamide required to make a 20kPa gel causing an increase in water 
absorption capacity. 
 
4.6 TNF-α secretion is not significantly affected by Actin repolymerization inhibition. 
Mechanosensing in cells requires modification of the actin cytoskeleton in order to generate the 
actin projections that form the focal adhesion points for rigidity sensing. In this experiment, 
RAW264.7 cells plated on 1, 5, 20 or 100kPa gels or glass were pretreated with Jasplakinolide 
prior to stimulation with CpG DNA or LPS. TNF-ELISA of cell supernatant revealed mostly 
insignificant difference between cells pretreated with Jasplakinolide and cells treated with 
DMSO vehicle alone, except in the cases of cells plated on 20kPa gel and stimulated with either 
CpG DNA or LPS, and cells plated on glass and stimulated with LPS (Figure 8). In all cases, the 
basal, unstimulated response was also high, suggesting that the cells did not receive sufficient 
inflammatory stimulus or the RAW264.7 cells being a stable, immortalized cell line contributed 
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to the seeming insensitivity to Jasplakinolide pretreatment. This could be also be tested by using 
bone marrow-derived macrophages instead and beginning the pre-treatment earlier in the process 
of adherence, for a longer duration with a sufficiently large cell population. Jasplakinolide 
efficacy could also be tested by evaluating apoptotic rates in the various cell populations (since 
Jasplakinolide has been shown to enhance the interleukin-2 apoptotic signal in CTLL-20 
interleukin-2-dependent T cells (Visegrady, 2005)), and determining whether substrate stiffness 
affects Jasplakinolide-induced apoptosis rates. 
 
4.7 Rho kinase expression is increased in cells plated on stiffer substrates. 
It was observed that expression of Rho kinase 1 (ROCK1) was highest in cells plated on glass, 
with the level of expression decreasing with the decrease in substrate stiffness (Figure 9). 
pROCK1 expression was too low to make any conclusions regarding the effect of substrate 
stiffness on ROCK1 phosphorylation and hence activity. This may be because the lysates were 
collected after the cells had been incubated overnight on the substrates: ROCK1 phosphorylation 
may have occurred within the first few hours of plating as the macrophages sensed their new 
environment. Neither ROCK1 nor pROCK1 were detectable in the lysate from cells plated on 
1kPa gel. Since tubulin expression was consistent across all the samples, lack of ROCK1 
detection is unlikely to be due to failure to detect protein. A likely explanation would be that 
initial mechanosensing of the soft 1kPa substrate was insufficient to drive formation of 
additional focal adhesion loci in the cytoskeleton. Therefore, the need of expression of additional 
Rho kinase over the (undetectable) constitutively present amount to form the adhesion bodies 
was absent. In contrast, the cells plated on 100kPa gel and glass generated large numbers of focal 
adhesion bodies and underwent extensive actin cytoskeletal rearrangement, thus necessitating 
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increased expression of ROCK1 We have previously seen that RAW 264.7 macrophages plated 
on stiffer substrates also show increased complexity in vinculin structures, i.e., increased number 
of focal adhesion points and thus mechanosensing capability (Figure 6A, E). Activation of Rho 
signaling is necessary for formation of focal adhesions (Ridley, 1992).  Therefore, our findings 
provide further evidence for increased mechanosensing in macrophages plated on stiffer surfaces 
and a corresponding lower degree of mechanosensing on more compliant substrates. In 
conjunction with the data showing an increase in TNF-α production from cells plated on 
compliant gels, this is additional support for the theory that compliant environments promote 
pro-inflammatory cytokine expression profiles in macrophages. Rho kinases are known to 
regulate macrophage motility (Van Goethem, 2010) and ROCK1 deficiency is known to impair 
monocyte-macrophage chemotaxis as well as hinder foam cell formation via reduced lipid uptake 
(loss of ability to traffic lipid-containing vesicles along the cytoskeleton), thus reducing foam 
cell accumulation and atherosclerotic lesion progression (Wang, 2008). Inhibition of ROCK-
mediated signaling also enhances uptake of apoptotic cells (Tosello-Trampont, 2003). Thus, 
ROCK1 and its downstream effectors could be potential therapeutic targets for the treatment of 
atherosclerosis.    
 
4.8 Model for macrophage involvement in the progression of atherosclerotic plaque. 
My research findings (summarized in Figure 10) demonstrate that surface rigidity regulates 
macrophage cytokine production. Bacterial phagocytosis and retention is enhanced in cells plated 
on stiffer substrates. Macrophages uptake and retain significantly more model lipid on compliant 
gels. While loss of mechanosensing via ROCK inhibition or actin repolymerization inhibition 
does not directly affect production of inflammatory cytokine TNF-α, the ability of cells to 
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recover and re-establish cellular adhesion decreases with increase in substrate compliance. These 
data add to our understanding of the following model (Figure 11) where macrophages react to 
the high compliance conditions of normal arteries or early lipid-rich atherosclerotic lesions by 
increasing efferocytotic activity and lipid uptake (Figure 11, panel 1). Once lipid accumulation 
exceeds the clearance capability of the macrophage population, the compliant environment 
enables increased lipid uptake but hinders lipid clearance, leading to formation of foam cells that 
add to the load of cells marked for apoptosis and exceed the efferocytotic capacity of the cells, 
which has been reduced due to the compliant environment (Figure 11, panel 2). This leads to 
buildup of lipids, cellular debris and toxic products of apoptosis, which stimulate 
proinflammatory cytokine production in macrophages and lead to the formation of a pliable 
necrotic core. In advanced lesions, the fibrotic cap is generated by surrounding endothelial cells, 
smooth muscle cells and macrophages in order to restore the mechanical integrity of the inflamed 
lesion. The cap provides a stiff environment for the functioning macrophages at the periphery of 
the necrotic core, reducing efferocytosis and anti-inflammatory cytokine production, leading to 
further inflammation and secondary necrosis, enlarging the necrotic core (Figure 11, panel 3). 
Increased production of matrix metalloproteases by macrophages (arising from monocytes which 
are continuously being recruited to the lesion site) promotes degradation of the fibrotic cap, 
increasing the likelihood of plaque rupture and subsequent thrombosis, which can be fatal 
(Figure 11, panel 4). 
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Figure 10: Summary of Research findings. Elasticity of tissues calculated from Tracqui, J. 
Struc. Biol., 2011. 
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Figure 11: Model of macrophage involvement in the progression of atherosclerotic plaque.  
On compliant normal arteries or early fatty streaks (panel 1), monocytes are recruited to the sites 
of excess lipid buildup, where they give rise to macrophages that take up excess lipid and 
efferocytose apoptotic cells. At this stage, macrophages produce anti-inflammatory cytokine 
(TGF-β) in larger amounts and limit lesion formation. Once lipid accumulation exceeds 
clearance capability of the resident macrophages (panel 2), lipid clearance falls behind lipid 
uptake, leading to formation of foam cells which in turn increase apoptotic load. Accumulation 
of lipids and cell debris in addition to proinflammatory cytokine production promotes lesion 
progression. In advanced, stiff lesions (panel 3), macrophage lipid uptake is also reduced, and 
increased lipid load in the environment creates cholesterol crystals which induce further 
inflammation and cytotoxicity. The increased apoptotic load is not efficiently cleared by 
macrophages (defective efferocytosis), contributing to secondary necrosis and the formation of a 
necrotic core. Increased matrix metalloprotease production leads to degradation and possible 
rupture of the fibrous cap (panel 4), releasing the toxic contents of the lesion into the lumen, 
where it induces platelet aggregation and thrombus formation. 
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4.9 Model for Rho/ROCK/Integrin mechanism in macrophage mechanosensing 
The mechanistic model of mechanosensing where integrin forms adhesions to ECM protein and 
signals actin cytoskeletal rearrangement is shown in Figure 12. Dynamic interactions of integrin 
heterodimers with ECM proteins exerts shear stress on the integrin molecule, activating the 
integrin dimer and initiating a signal cascade starting with the activation of focal adhesion kinase 
(FAK) and tyrosine protein kinase CSK (c-Src), phosphorylating signal adaptor proteins such as 
paxilin (PAX), cellular apoptosis susceptibility protein (CAS) and adapter molecule Crk (Shyy, 
2002). Guanine exchange factors such as C3G convert the small GTPase RhoA to RhoA-GTP. 
This acts on ROCK, which inhibits myosin light chain (MLC) phosphatase and promotes MLC 
phosphorylation, increasing myosin II activity and causing shortening of actin fibers to form 
actin stress fibers (Maekawa, 1999). ROCK also activates LIM kinase (LIMK), which 
phosphorylates cofilin, inactivating its actin-depolymerization activity (Wang, 2009). Actin 
polymerizes to form filaments, which link to integrins via intermediaries such as paxilin, 
vinculin and talin, forming the focal adhesion complex. 
 
ROCK1 is ubiquitously distributed in tissues and is the primary form of ROCK expressed in 
macrophages (Riento, 2003). It is therefore the primary form of ROCK that is responsible for 
mechanosensing in macrophages and thus would be important in modifying macrophage 
behavior. 
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Figure 12: Mechanism of integrin stiffness signaling to ROCK via Rho. ECM proteins exert 
mechanical shear stress on inactive integrins, switching them to an active configuration. Specific 
interaction of the α-integrin with FAK and c-Src initiates the phosphorylation cascade of adaptor 
molecules (CAS, PAX, Crk) and guanine nucleotide exchange factors (C3G), phosphorylating 
Rho-GDP to Rho-GTP. Rho then acts on ROCK, which inhibits MLC phosphatase and promotes 
myosin light chain (MLC) phosphorylation, initiating actin fiber contraction. Additionally, 
ROCK activates LIM kinase, which phosphorylates cofilin, inactivating it and promoting actin 
filament stabilization. The actin filaments then attach to the integrin via paxilin to form the focal 
adhesion complex. 
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